Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Candidemia D058387 2 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Xerostomia D014987 6 associated lipids
Vaginitis D014627 6 associated lipids
Urethritis D014526 9 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Peritonitis D010538 38 associated lipids
Otitis Externa D010032 8 associated lipids
Mycoses D009181 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Influenza, Human D007251 11 associated lipids
Hypertension D006973 115 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hemolysis D006461 131 associated lipids
Gonorrhea D006069 7 associated lipids
Dermatomycoses D003881 17 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Burns D002056 34 associated lipids
Body Weight D001835 333 associated lipids
Blastomycosis D001759 5 associated lipids
Aspergillosis D001228 5 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Ramaswamy M et al. Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma. 1999 Antimicrob. Agents Chemother. pmid:10348764
Clements-Jewery S Nystatin-induced potassium efflux from Saccharomyces cerevisiae measured by flame photometry: a potential bioassay approach. 1976 Antimicrob. Agents Chemother. pmid:773299
Hsuchen CC and Feingold DS Selective membrane toxicity of the polyene antibiotics: studies on natural membranes. 1973 Antimicrob. Agents Chemother. pmid:4586145
Meletiadis J et al. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. 2002 Antimicrob. Agents Chemother. pmid:11751112
te Welscher YM et al. Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. 2010 Antimicrob. Agents Chemother. pmid:20385867
Hsuchen CC and Feingold DS Selective membrane toxicity of the polyene antibiotics: studies on lecithin membrane models (liposomes). 1973 Antimicrob. Agents Chemother. pmid:4758835
Randhawa P et al. BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport. 2007 Antimicrob. Agents Chemother. pmid:17893158
Badaracco G and Cassani G Ribonucleic acid synthesis dependent on exogenous triphosphates in nystatin-treated cells of of Kluyveromyces latis. 1976 Antimicrob. Agents Chemother. pmid:949173
Serfling A et al. Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. 2007 Antimicrob. Agents Chemother. pmid:17620378
Razonable RR et al. Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism. 2005 Antimicrob. Agents Chemother. pmid:16048981
Oakley KL et al. Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole. 1999 Antimicrob. Agents Chemother. pmid:10223948
Retamales P et al. Complementation analysis with new genetic markers in Phaffia rhodozyma. 1998 Antonie Van Leeuwenhoek pmid:9801767
Kovalchik MT and Kraus SJ Neisseria gonorrhoeae: colonial morphology of rectal isolates. 1972 Appl Microbiol pmid:4624216
Patel PV and Johnston JR Dominant mutation for nystatin resistance in yeast. 1968 Appl Microbiol pmid:5636460
Huhtanen CN and Pensack JM Effect of antifungal compounds on aspergillosis in hatching chick embryos. 1967 Appl Microbiol pmid:5298442
Merkal RS and Richards WD Inhibition of fungal growth in the cultural isolation of mycobacteria. 1972 Appl Microbiol pmid:4561102
Plourde R and Hafez-Zedan H Distribution of steroid 1-dehydrogenation and side-chain degradation enzymes in the spores of Fusarium solani: causes of metabolic lag and carbohydrate independence. 1973 Appl Microbiol pmid:4699223
James AN et al. Variation in colonial morphology of Neisseria gonorrhoeae after growth on media containing antimicrobial agents. 1973 Appl Microbiol pmid:4201640
Wang W et al. The interaction of polysaccharide from Auricularia polytricha with quantum dots and the protection of plasmid DNA from damage. 2013 Appl. Biochem. Biotechnol. pmid:23440638
Kasbekar DP and Papavinasasundaram KG An inducible, nondegradative phytoalexin resistance mechanism in Dictyostelium discoideum is suppressed by mutations that alter membrane sterol composition. 1992 Appl. Environ. Microbiol. pmid:1622285